birdseye - on my reading of the orphan drug regime Ovarian cancer therapeutics do qualify as while the INCIDENCE is at the high end of the range, the PREVALENCE is comfortably within the parameters due to relatively short life expectancy.
There is a clear precedent for ovarian cancer treatments being given Orphan status.
CVac will get this designation, no worries.
- Forums
- ASX - By Stock
- all about orphan drug status
birdseye - on my reading of the orphan drug regime Ovarian...
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.010(2.78%) |
Mkt cap ! $537.4M |
Open | High | Low | Value | Volume |
36.0¢ | 37.0¢ | 36.0¢ | $563.7K | 1.544M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 386559 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 261422 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 359162 | 0.365 |
8 | 255553 | 0.360 |
6 | 112661 | 0.355 |
9 | 182977 | 0.350 |
4 | 33307 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 261422 | 13 |
0.375 | 212456 | 8 |
0.380 | 132165 | 8 |
0.385 | 82622 | 5 |
0.390 | 182494 | 4 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online